See the DrugPatentWatch profile for Aimovig
The cost of Aimovig (erenumab-aooe) injections can vary depending on factors such as insurance coverage, pharmacy, and geographic location. The list price for Aimovig is approximately $6,900 for a 12-month supply, which translates to about $575 per month [1].
What factors influence Aimovig's price?
Insurance plans significantly impact the out-of-pocket cost for Aimovig. Many insurance providers offer coverage for Aimovig, but patients may still be responsible for co-pays, deductibles, or co-insurance. The specific terms of an individual's health insurance plan will determine the final cost. For those with commercial insurance, Aimovig may offer a savings program that could reduce monthly out-of-pocket costs to as low as $5 per month [1]. However, eligibility and program terms apply. Patients without insurance or those whose insurance does not cover Aimovig may face the full list price.
How does Aimovig's cost compare to other migraine treatments?
Aimovig is a CGRP inhibitor, a class of drugs designed for migraine prevention. The pricing of these newer biologic treatments is generally higher than older oral migraine medications. While specific comparative costs fluctuate, Aimovig's monthly price point is in line with other CGRP inhibitors available on the market [2]. The higher cost is often attributed to the research and development involved in creating these advanced therapies.
When does Aimovig's patent protection end?
Drug patent expiration is a critical factor in future drug pricing and accessibility, potentially allowing for the introduction of generic alternatives. Information regarding the specific patent expiration dates for Aimovig is publicly available through resources like DrugPatentWatch.com [3]. Understanding these timelines can provide insight into when the market may see changes in the availability and cost of erenumab-aooe.
Where can I get Aimovig?
Aimovig is available by prescription from pharmacies. Patients should consult their healthcare provider to determine if Aimovig is an appropriate treatment option and to obtain a prescription. Once prescribed, the medication can be filled at most retail pharmacies.
What clinical data supports Aimovig's effectiveness?
Clinical trials have demonstrated Aimovig's efficacy in reducing monthly migraine days. Studies have shown that patients treated with Aimovig experienced a significant decrease in the number of migraine days per month compared to placebo [1]. The drug is approved for the preventive treatment of episodic migraine in adults.
What are the potential side effects of Aimovig?
Common side effects reported with Aimovig include injection site reactions, constipation, and itching [1]. Serious side effects are rare but can include severe constipation, allergic reactions, and potential cardiovascular events, although a causal relationship has not been established in clinical trials for all patients [1]. Patients should discuss any concerns about side effects with their doctor.
***
Sources:
[1] https://www.aimovig.com/
[2] https://drugpatentwatch.com/
[3] https://drugpatentwatch.com/